E. Greinel

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

G. Barger, S. Reingold, C. Bever, 2000, Multiple sclerosis.

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

J. Wolinsky, H. Panitch, C. Ford, 2006, Multiple sclerosis.

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

C. Bever, L. Weiner, J. Wolinsky, 2000, Multiple Sclerosis.

United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center.

J S Wolinsky, J. Wolinsky, P. Narayana, 2001, Multiple sclerosis.